TokenPost·
Arcturus Therapeutics Narrows Q3 Net Loss to $7.4 Million
The company recorded a $0.26 GAAP loss per share. Collaboration revenue rose to $16.9 million, while grant revenue fell to $1.4 million.
More news
- TokenPostIren Targets $25 Billion in Capital Spending After $25B-$30B Guidance
- TokenPostTrump Blames Midterm Results for Historic Stock Market Setback
- CryptoSlateMEXC sees $126 million outflows as US targets exchange over $16.7 billion in suspected illicit transactions
- TokenPostZiff Davis’ Operating Results Swing to Loss as Revenue Falls 5.6%
- TokenPostTokenized iShares MSCI South Korea ETF (EWY) Falls 1.22% as Price Sits Below Averages
- TokenPostJim Cramer Says AI Stock Sell-Off Differs From Dot-Com Crash